Hermelin, Chairman of the Board and Chief Executive Officer stated, "KV enjoyed a solid third quarter, including growth at ETHEX due to continued revenue contribution from the 100 mg and 200 mg strengths of Metoprolol Succinate Extended Release Tablets and our Diltiazem HCl Extended- Release Capsules.
The Company expects increased contribution from both Diltiazem HCl Extended Release Capsules and its two strengths of Metoprolol Succinate Extended Release Tablets for the remainder of fiscal 2008 and beyond.
Biovail Corporation (NYSE:BVF) (TSE:BVF) today announced that it has received approval from the Food and Drug Administration for its New Drug Application of a novel once daily controlled release formulation of Diltiazem Hcl.
The company broadened its product base during the year with the FDA approvals of acyclovir injection for the treatment of herpes simplex and diltiazem HCL injection for the treatment of irregular heartbeats.
This launch is the first part of an alliance in which Taylor and Baxter will jointly develop, manufacture and market four injectable products with current sales in excess of $200 million: Ketorolac Tromethamine Injection, Amrinone Lactate Injection, Diltiazem HCl Injection and Labetalol HCl Injection.